NARCOLEPSY
Clinical trials for NARCOLEPSY explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY trials appear
Sign up with your email to follow new studies for NARCOLEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep narcolepsy patients awake and steady
Symptom relief Not yet recruitingThis study tests a drug called samelisant in 240 adults with narcolepsy (with or without sudden muscle weakness). The goal is to see if it reduces severe daytime sleepiness and weekly episodes of cataplexy over 12 weeks. Participants will be randomly assigned to receive either sa…
Matched conditions: NARCOLEPSY
Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New pill aims to fight narcolepsy sleepiness
Symptom relief Not yet recruitingThis study tests an experimental drug called E2086 in 64 adults with narcolepsy to see if it reduces excessive daytime sleepiness and cataplexy (sudden muscle weakness). Participants will receive either E2086 or a placebo for 4 weeks. The main goal is to measure how well they can…
Matched conditions: NARCOLEPSY
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Nightmare relief for narcolepsy: new therapy shows promise
Symptom relief Not yet recruitingThis study tests a non-drug therapy called Imagery Rehearsal Therapy to see if it can reduce nightmares in adults with narcolepsy. About 80 participants will receive the therapy and complete three assessments. Half get the therapy right away, the other half after a delay. The goa…
Matched conditions: NARCOLEPSY
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC